Filing Details

Accession Number:
0001178913-11-002766
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-06 16:24:14
Reporting Period:
2011-10-04
Filing Date:
2011-10-06
Accepted Time:
2011-10-06 16:24:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1176309 Oramed Pharmaceuticals Inc. ORMP.OB Pharmaceutical Preparations (2834) 980376008
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1416089 Leonard Sank 3 Blair Road
Cape Town T3 8005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-04 937,500 $0.32 937,500 No 4 P Indirect Via spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Via spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2011-10-04 328,125 $0.00 0 $0.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
328,125 2011-01-25 2016-01-25 No 4 A Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 500,000 Indirect Via trust
Common Stock 2,357,650 Direct
Footnotes
  1. The 937,500 shares of Common Stock and the warrant to purchase 328,125 shares of Common Stock were purchased in January 2011 on behalf of a company wholly owned by a trust of which the Reporting Person is a trustee and 30% of the beneficiaries are members of the Reporting Person's immediate family. Accordingly, the Reporting Person may be deemed to have acquired indirect beneficial ownership of 30% of such securities when they were acquired by such company. The Reporting Person disclaims such beneficial ownership.
  2. These shares represent 30% of the shares owned by a company wholly owned by a trust of which the Reporting Person is a trustee and 30% of the beneficiaries are members of the Reporting Person's immediate family. Accordingly, the Reporting Person may be deemed to have indirect beneficial ownership of these shares. The Reporting Person disclaims such beneficial ownership.